Medication info
Anadip Tablets 10 Milligrams (Lercanidipine Hydrochloride)

Anadip Tablets 10 Milligrams (Lercanidipine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200500694 · Notified 2005.07.26 · Insurance code 654000630

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become apparent. For patients whose blood pressure is not controlled with this medicine, combination treatment with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril or enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and instead increase adverse reactions. ○ Older adults : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is needed when initiating treatment in older adults. ○ Patients with hepatic or renal impairment : Special caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosing pattern for these patients is consistent, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to control blood pressure in patients with mild to moderate essential hypertension.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become apparent. For patients whose blood pressure is not controlled with this medicine, combination treatment with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril or enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and instead increase adverse reactions. ○ Older adults : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is needed when initiating treatment in older adults. ○ Patients with hepatic or renal impairment : Special caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosing pattern for these patients is consistent, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This medication should not be administered to certain patients. For example, those with an allergy to this medication or similar drugs, pregnant or breastfeeding women, patients with left ventricular outflow obstruction, untreated congestive heart failure, unstable angina, severe liver or kidney impairment, patients who have recently experienced acute myocardial infarction, patients undergoing dialysis, children or adolescents under 18 years of age, and those with genetic lactose intolerance problems should not use this medication. Additionally, this medication should be carefully administered to some patients with cardiovascular problems, mild to moderate kidney or liver dysfunction, a history of angina, frequent alcohol consumption, and especially elderly patients. When taking this medication, various side effects may occur. Symptoms such as facial flushing, peripheral edema, palpitations, headaches, dizziness, fatigue, indigestion, nausea, vomiting, abdominal pain, and diarrhea can appear. Regular liver function tests are necessary, as liver function abnormalities may develop, and gingival hyperplasia may also occur, requiring monitoring. Skin rashes and myalgia have also been reported. This medication may worsen symptoms if suddenly discontinued, so it should be tapered off gradually under a physician's guidance. Caution is also needed while driving or operating machinery, as dizziness or drowsiness may occur. This medication is metabolized by a specific enzyme (CYP3A4) in the liver, so taking it alongside other medications that inhibit or activate this enzyme may alter its effect. For instance, taking antifungals, certain antibiotics, immunosuppressants, anticonvulsants, and grapefruit juice can increase blood concentration and the risk of side effects; hence caution is required. Moreover, alcohol consumption can enhance the vasodilatory effects of this medication, increasing the risk of hypotension, so it is advisable to avoid it. Pregnant or potentially pregnant women and nursing mothers should not use this medication. Animal studies have documented negative effects on fetuses when high doses are administered, and there is a possibility that it could be excreted in breast milk. Safety and efficacy have not been established for children or adolescents under 18 years of age, so it is not used in this population. Elderly patients may experience different drug metabolism and responses; therefore, special caution is needed during initial administration. In the case of overdose, severe hypotension, rapid heart rate, drowsiness, and cardiac shock can occur; immediate medical attention is required, and cardiovascular status should be monitored for at least 24 hours. Blood dialysis may not effectively remove this medication. Lastly, this medication should be kept out of reach of children, and transferring it to other containers can adversely affect the quality of the drug, so caution should be exercised.

Side effects

  • Flushing
  • peripheral edema
  • palpitations
  • tachycardia
  • hypotension
  • chest pain
  • angina
  • headache
  • dizziness
  • asthenia
Show 29 more
  • fatigue
  • drowsiness
  • neurosis
  • dyspepsia
  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • increased serum aminotransferase levels
  • polyuria
  • nocturia
  • gingival hyperplasia
  • rash
  • myalgia
  • tremors
  • insomnia
  • dry mouth
  • hand tingling
  • cough
  • abdominal bloating
  • erectile dysfunction
  • arrhythmia
  • cold sweat
  • skin tingling
  • premature contractions
  • tongue rigidity
  • increased ventricular premature beats
  • dyspnea
  • gastrointestinal disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and humidity; therefore, it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.